This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Candesartan Cilexetil 8 mg tablets. The $12,219.68 firm fixed price contract has an ultimate completion date of August 2, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for delivering a wide...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets. The contract has an ultimate completion date of January 24, 2025 and a ceiling value of $15,714.20. AmerisourceBergen is a major pharmaceutical distributor that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a wide range...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Candesartan Cilexetil 32 MG Tablets in 90-count bottles. The Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,832.28, is for the provision of Candesartan Cilexetil 32 mg tablets. The contract is a firm fixed-price delivery order with a period of performance through November 6, 2024. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger...
This is a $23,928.65 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets. The contract has an ultimate completion date of April 3, 2025 and is a firm fixed-price contract. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of...
This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, to provide 4,566,271,119 units of the pharmaceutical drug Candesartan Cilexetil 32 mg. The delivery order has a firm fixed-price contract type, a ceiling value of $7,881.24, and a period of performance through October 31, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $5,528.55 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 32 mg Candesartan Cilexetil tablets in 90-count bottles, with a completion date of September 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999, which provides a range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of 32 mg Candesartan Cilexetil tablets, a pharmaceutical product, and has a ceiling value of $14,864.29. The contract is a firm-fixed price delivery order with an ultimate completion date of October 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S....
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 32 mg tablets in 90-count packages. The contract has a firm fixed price of $15,438.32 and an ultimate completion date of June 10, 2025. This contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a large Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $3,734.76, is for the supply of Candesartan Cilexetil 8 mg tablets. The contract has an ultimate completion date of April 23, 2025 and is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corporation holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...